Skip to content

ENAVATE SCIENCES GP, LLC: BRVE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ENAVATE SCIENCES GP, LLC on BRVE, newest first. How the timeline and the estimate are built.

ENAVATE SCIENCES GP, LLC held 3,674,656 BRVE shares at 2026-09-30 per its 13F-HR filed 2026-11-16.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 3,674,656 shares
    Change vs previous 13F not available

    26.53% of the 13F portfolio, value $74,228,051.

    13F-HR 0001953107-26-000019 filed by ENAVATE SCIENCES GP, LLC
    Accepted , ingested